With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Artificial intelligence (AI) is transforming medical research by revealing data patterns that can be used to predict disease and treatment outcomes for individual patients. To realize the potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results